JNPmedi
Digital clinical trial platform streamlining healthcare R&D.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | N/A | Growth Equity non VC | |
| Total Funding | 000k | ||
Related Content
Based in Seoul, South Korea, J&P Medi (also known as JNPMEDI Inc.) was founded in 2020 by CEO Jeong-ho Jeon with the objective of advancing South Korea's medical infrastructure through digital technology. The company operates in the healthcare IT sector, specifically focusing on digitalizing and streamlining clinical research and trial operations for pharmaceutical, biotech, and medical device companies.
The core of J&P Medi's offering is the 'Maven Clinical Cloud', a proprietary, end-to-end eClinical solution. This platform is designed to manage and analyze clinical trial data, leveraging technologies like blockchain and cloud computing to enhance security and efficiency. Key modules include Maven CDMS (Clinical Data Management System), which features Electronic Data Capture (EDC), and specialized solutions for electronic clinical outcome assessments (eCOA), document management (Maven Docs), and adverse event reporting (Maven Safety). The platform aims to reduce the time and costs associated with clinical research by offering integrated, one-stop services.
The company's business model is primarily subscription-based, with tiered plans such as maven standard, maven professional, and maven extensive. In addition to its software solutions, J&P Medi expanded its services in 2024 to include professional consulting in areas like digital transformation strategy, clinical operations, and regulatory strategy. The company has secured funding from investors including AJU IB Investment, Kakao Ventures, and Murex Partners. A seed round in December 2021 was followed by a Series A funding round in November 2022, raising $10.3 million.
Keywords: clinical trial software, eClinical solutions, medical data platform, healthcare IT, pharmaceutical research, biotech services, medical device trials, Maven Clinical Cloud, clinical data management, digital transformation in healthcare, blockchain in clinical trials, regulatory strategy consulting, life sciences R&D, drug development technology, Series A, South Korea, HealthTech, medical software, clinical operations, data security